analgesic efficacy of the patient controlled inhaled Nitrous oxide with intravenous opioids (Pethidine &
Conditions
Interventions
the participants were instructed to begin inhalation Nitrous oxide via mouthpiece 2 minutes before start procedure and continue inhaling gas when she felt pain or until end of procedure. If the partic
Experimental Drug,Active Comparator Drug
Nitrous oxide group,Pethidine group
Sponsors
Endowment fund, Faculty of Medicine, Chiang Mai University
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Female, 18 years of age or older 2. Treat with dilatation and curettage, fractional curettage and MVA 3. Able to self-controlled inhaled Nitrous oxide 4. Volunteer to participate
Exclusion criteria
Exclusion criteria: 1. hemodynamic unstable 2. contraindication for Nitrous oxide or Pethidine/Midazolam such as history of severe respiratory or cardiac disease, thyroid disease, neurological disorder, renal disorder 3. upper respiratory infections or sinus blockage, recent history of middle or inner ear surgery, pneumothorax or intestinal obstruction 4. ASA physical status III/IV 5. history of curettage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score during procedure, immediately post-procedure, 30-mins post-procedure Numerical Rating Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| satisfactory level, side effects, discharge time post-procedure questionnaire interview | — |
Countries
Thailand
Contacts
Public ContactNapas Lohtrakul
Faculty of Medicine, Chiang Mai University
Outcome results
None listed